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A B S T R A C T
The future of surgical progress depends on surgeons ﬁnding innovative solutions to their patients’ problems.
Surgical innovation is critical to advances in surgery. However, surgical innovation also raises a series
of ethical issues that challenge the professionalism of surgeons. The very criteria for deﬁning surgical
progress have changed as patients may value more than simply reductions in morbidity and mortality. The
requirement for informed consent prior to surgery is difﬁcult when an innovative surgical procedure is
planned since the risks of the novel operation may not be known. In addition, even if the risks are known
in the hands of the innovator, the actual risks to patients when surgeons are learning the new technique
are unknown. New techniques often depend on new technology which may be signiﬁcantly more expensive
than traditional techniques. There are no clear criteria to decide which new innovative techniques are going
to turn out to be truly beneﬁcial to patients. Many surgical innovations depend on new products which may
have been developed as collaborative efforts between surgical device companies and surgeons. Although
many currently accepted therapies were developed in this fashion, the collaboration of surgeons and device
companies raises the potential for signiﬁcant harmful conﬂicts of interest. In the decades to come, careful
attention to these and other ethical issues will help to deﬁne the future professional standing of surgeons.
© 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
1. Introduction
Much has been written about the contributions that Professor Renzo
Dionigi hasmade to the practice of surgery. He is esteemed as a skilled
surgical investigator, a gifted practitioner of surgery, and a thoughtful
surgical educator. He has contributed over 800 peer-reviewed articles
to the medical and surgical literature in areas including surgical
infections, surgical nutrition, and surgical oncology. There is uniform
agreement that he is an innovator in surgery. For these reasons, there
is no better time than at the celebration of Professor Dionigi’s career
to consider in more detail the challenges and promise of surgical
innovation to the future of surgery.
During the decades Professor Dionigi has been in practice, we
have seen remarkable advances in surgical science that have led
to signiﬁcant improvements in patient care. This record of surgical
progress has depended on the efforts of many innovators in surgery
who have creatively considered how to solve their patients’ problems
by doing something different. Despite the record of achievement in
surgical innovation, the future of surgical innovation raises a number
of important ethical issues for the care of surgical patients. These
are not simply hypothetical issues, but actually practical issues that
may threaten the professional standing of surgeons in the decades to
come.
2. Professionalism and surgery
In recent years, many authors have addressed the importance of
professionalism in medicine and surgery. Since 2005, the following
books on professionalism have been published:
Measuring Medical Professionalism by David Thomas Stern, 2005
Professionalism in Medicine: Critical Perspectives by Delese Wear and
Julie M. Aultman, 2006
Living Professionalism: Reﬂections on the Practice of Medicine by Erin A.
Egan, Patricia M. Surdyk, Mona Ahmed and Amy Bernstein, 2006
Educating for Professionalism: Creating a Culture of Humanism in
Medical Education , by DeleseWear, Jordan J. Cohen, and Janet Bickel,
2008
Teaching Medical Professionalism by Richard L. Cruess, Sylvia R. Cruess
and Yvonne Steinert, 2008
Professionalism in Medicine by Jill Thwistlethwaite and John Spencer,
2008
Professionalism in Medicine: A Case-based Guide for Medical Students
by John Spandorfer, Charles A. Pohl, Susan L. Rattner and Thomas J.
Nasca, 2009
Professionalism in Health Care: A primer for Career Success by Cherry
Makely, 2012
Although this list is by no means exhaustive, it suggests the
tremendous attention that is being paid to professionalism in the
practice of medicine and surgery today.
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Although the deﬁnitions of “professionalism” in surgery are
certainly many and varied, for our purposes the following deﬁnition
is most helpful: “In return for professional autonomy, self-regulation,
and a recognition of their unique place in society, the public demands
of physicians accountability, ethical standards and an altruistic
manner of delivering care.”. 1 The central concept in this deﬁnition of
professionalism is that the surgeon’s motivation in decision making
is the beneﬁt of the patient. The “altruistic manner of delivering
care” emphasizes that the beneﬁt of the patient is of paramount
importance regardless of whether there is beneﬁt to the surgeon.
As will be evident in the following paragraphs, the ethical issues
in surgical innovation challenge the professionalism of surgeons in
multiple ways.
3. Surgical innovation and surgical progress
The traditional criteria for surgical progress have been reductions
in patient morbidity and mortality. Complications and deaths are
objective criteria that can be readily measured. Other commonly
used outcome measures to determine if surgical innovations are
beneﬁcial have been other objective criteria such as increases in
disease-free survival, reductions in recurrence rates, or shortened
lengths of stay. For years, when deciding whether a novel surgical
approach is beneﬁcial to patients, objective criteria, such as these,
have been assessed.
The history of surgery makes it clear that not all new ideas
are good ideas. For example, internal mammary artery ligation for
the treatment of angina and gastric freezing for the treatment of
ulcer disease were both innovative approaches that were originally
thought to be good for patients. The presumed beneﬁts of these
procedures were purported to be the reduction in subjective
symptoms of patients. Unfortunately, many things can inﬂuence a
patient’s subjective assessment of symptoms and over time, it became
clear that internal mammary artery ligation and gastric freezing are
not actually effective in reducing these subjective symptoms. Only
with rigorous study to carefully assess these outcomeswas it possible
to show that these widely accepted surgical procedures were not
effective and therefore did not constitute surgical progress. 2,3
In recent years, a number of innovative surgical procedures have
been proposed that have little if any impact on morbidity and
mortality, but instead are primarily focused on changing the cosmetic
outcomes for patients. For example, natural oriﬁce translumenal
endoscopic surgery (NOTES), single incision laparoscopic surgi-
cal (SILS) techniques, and remote access approaches to thyroidectomy
(e.g., robotic assisted transaxillary thyroidectomy) are all techniques
that either move or eliminate some of the scars associated with
the surgical procedure. The beneﬁt derived by patients from such
procedures is, therefore, more challenging to assess. If, for example,
a SILS approach was used during a laparoscopic adrenalectomy, we
could only determine the beneﬁt to the patient by examining the
patient’s subjective assessment of the scar and whether having one
scar is better than having 3 or 4 scars. Such “minimally invasive”
approaches as those noted above, therefore, have created a much
broader notion of what is “beneﬁcial” to patients.
Whereas surgeons could traditionally assess the success of a
surgical innovation by objectively measuring certain speciﬁed out-
come measures, many of the newer techniques are only potentially
beneﬁcial to patients if the patients place a signiﬁcant value on the
cosmetic change of the innovation. In this context, we are seeing
a signiﬁcant shift away from surgeon-deﬁned beneﬁt to patient-
deﬁned beneﬁt. 4 As such, the determination of how much beneﬁt
the patient derives can only be determined by carefully questioning
the patient. 5 Such subjective beneﬁts may be equally important to
patients as the traditional objective criteria, but it is clearly more
difﬁcult to assess these potential beneﬁts that are purely subjective. In
addition, it becomes critical to ensure that the patient truly values the
cosmetic change that the innovative technique offers. For this reason,
surgical progress becomes amuchmore nebulous concept since it can
only be deﬁned relative to a speciﬁc patient’s values.
Given the challenge of even determining whether an innovative
approach is beneﬁcial relative to a speciﬁc patient’s values, in
the current era of assessing surgical innovation, we must develop
increasingly sensitive assessments of patient’s subjective outcomes.
The potential for bias and the placebo effect are greatwhen subjective
outcomes are the criteria of success of an innovative procedure. 6
4. Informed consent and the risks of innovative surgery
One of the central ethical challenges to the performance of innovative
surgical procedures is how informed consent can be effectively
obtained from patients. In order to obtain valid informed consent
from a patient prior to surgery, the patient must have the capacity
to make a decision regarding his or her best interests. The patient
must be offered the opportunity to be informed of the risks, beneﬁts,
and alternatives of the procedure so that a decision can be made.
As is readily apparent, if a patient is being offered an innovative
surgical procedure, the surgeonmay not knowwhat the risks actually
are. As such, the disclosure of unknown risks is impossible. In this
circumstance, the best that can be done is for the surgeon to explain
the limits of knowledge about the new procedure and the uncertainty
about what the risks of the novel procedure actually are. Although it
is possible to explain the lack of knowledge about the risks and for the
patient to consent to a procedurewith unknown risks, such disclosure
of unknown risks is very challenging both for surgeons to explain and
for patients to understand.
If an innovative procedure has been performed on multiple
occasions by the surgeon, he or she may have at least some idea of
what the risks and beneﬁts are. In such a circumstance, the surgeon
should explain to the patient what is known about the risks and
beneﬁts. However, even with the performance of an operation many
times, a surgeonmay not have an accurate understanding of what the
actual risks of the operationmay be. If an operation carries a 1–2% risk
of a particular complication, a surgeon might have to perform the
operation many thousands of times in order to prove that the risks
of the innovative procedure were doubled. 5 For example, despite
the large numbers of laparoscopic cholecystectomies that were
performed in the early years of the adoption of the technique in the
USA, individual surgeons failed to acknowledge the increased risks
of common bile duct injury. The realization that the risks of injury
to the common bile duct were signiﬁcantly increased occurred only
after the New York State Department of Health tabulated a registry of
complications of laparoscopic cholecystectomy and realized a 15-fold
increase in the risk of serious injuries to the common bile duct in
laparoscopic cholecystectomies compared to the conventional open
approach. 7,8
Another ethical challenge of the informed consent process in
innovative surgery is the inherent bias that both surgeons and
patients often bring to the interaction. It is widely accepted in
contemporary culture that what is “new” is “improved”. Undoubtedly
patients can be inﬂuenced by this assumption especially when the
proponents of a new techniquemay have been vocal about promoting
beneﬁts in the lay press even before any large studies are completed.
In addition, surgeons and medical institutions are also often strongly
inﬂuenced by the optimism bias that often accompanies innovative
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procedures. 9 In a circumstance where the patient may already
assume that the novel technique is better and the surgeon is also
biased toward the new procedure, there is signiﬁcant risk that the
informed consent process will not include a balanced discussion of
the potential and unknown risks of the innovative procedure.
5. Safety and the learning curve
Even if one could get past the uncertainty about the risks of innovative
surgical procedures, another central ethical issue is that even when
the original innovator has moved beyond his or her early experience,
as an operation becomes performed at othermedical centers by other
surgeons, the problem of the learning curve arises. The “learning
curve” refers to the increased risks to patients during the time that a
surgeon and surgical team need to become comfortable with a new
procedure. 10 The ethical challenge with disclosure of the learning
curve to patients is that it is most often not apparent to a surgeon
when the steep portion of the learning curve has passed except in
retrospect. In other words, it becomes very difﬁcult to disclose the
risks of the learning curve to patients when those risks may be
unknown. Nevertheless, adequately informing the patient of one’s
experience with an innovative procedure is a minimal expectation of
the informed consent process.
6. Financial costs of innovative surgery
New procedures are often dependent on new technology that
is almost always more expensive than what was used with the
conventional operation. 10 This additional cost may have implications
for the availability of the innovative surgical procedure to the wider
population. Depending on the health system, the additional costs
might make the new procedure only available to those afﬂuent
enough to pay for it or the additional costs may be spread across
the entire health system and take resources from other conventional
therapies that might have proven beneﬁt. Although what is costly
is inherently neither good nor bad, we must clearly assess the cost
implications of embarking on innovative procedures.
Whether innovative surgery is dependent on new technology or
not, there is another signiﬁcant cost that must be considered –
namely, operative time. The new procedure almost always takes
longer than the conventional procedure. Since operating room time is
an expensive and limited commodity, there are signiﬁcant costswhen
a surgeon decides to offer an innovative procedure that may take
twice as long in the operating room. How such increased costs should
beweighed against the potential beneﬁts to the individual patient is a
complex determination.We currently have fewguides to helpmanage
the potentially opposing tensions of meeting an individual patient’s
wishes relative to the costs to the systemof the innovative procedure.
7. Potential conﬂicts of interest
Whenever discussing surgical innovation, we must not ignore the
signiﬁcant potential for conﬂicts of interest for the surgical innovators
in their relationships with the companies that manufacture the tech-
nology that makes the innovation possible. The history of innovation
in surgery has numerous examples of how the relationships between
surgeons and industry have led to signiﬁcant patient beneﬁt.Without
the input of surgeons, companies often would lack the knowledge of
where to focus attention in developing new products. Unfortunately,
there are alsomany examples of surgeons proﬁting greatly fromusing
certain products. Whenever individual surgeon decision making for a
patient is inﬂuenced by the potential to make large sums of money,
there is the potential for signiﬁcant abuse. Although interactions
between surgeons and industry are important for the future beneﬁt
of patients, determining exactly how such interactions should occur
while avoiding signiﬁcant conﬂicts of interest is a critical challenge
for the future. We must ensure that the decisions made by surgeons
beneﬁt the patient and not just the surgeon.
8. When to “jump on the bandwagon”
One of the major problems with innovation in surgery is that at the
outset of the experience with an innovative procedure it is never
known whether the new idea will be a good idea that helps
patients. Consider the early experience that many surgeons had
with laparoscopic cholecystectomy. Here was a new operation that
required expensive equipment and took longer to complete. Formany
surgeons, the early experience with laparoscopic cholecystectomies
was that the operation took three to ﬁve times longer than a
conventional cholecystectomy. If the decision had been made to
abandon the operation based on this early experience, we would
never have realized the tremendous beneﬁts that patients have
accrued from not only laparoscopic cholecystectomy but from
numerous other laparoscopic operations.
We know that the learning curve is real and that as surgeons
becomemore adept at an operation the operative times decrease and
efﬁciency increases. However, with an innovative surgical procedure,
if there is no prior experience with the operation, it is completely
unknown what the outcomes may be after surgeons have moved
beyond the learning curve. Surgical innovation depends, at least to
some extent, on the “trial and error” method of trying out many
different novel procedures in the hopes that some will prove to be
of signiﬁcant beneﬁt to patients. It is imperative that as surgeons
evaluate the results of innovative surgery, they must carefully
scrutinize patient outcomes so that patient beneﬁt becomes the
driving force to decide whether to continue to pursue the novel
procedure.
9. Conclusions
In the preceding paragraphs, we have explored a number of ethical
challenges to the future of innovative surgery. It is clear that
surgeons may signiﬁcantly beneﬁt from innovative surgery both
professionally and ﬁnancially. The surgeon who develops a new
technique is the surgeon who can increase his or her practice and
potentially becomes the expert on that new operation. All of these
things tend to encourage the surgeon to continue to push for the
innovative procedure. However, in order to uphold the standards of
professionalism, the surgeon must be driven by altruistic motives
rather than self-interest. In order for surgeons to maintain their
position as professionals in society, they must not allow the lure
of the new and the potential for ﬁnancial beneﬁt to inﬂuence their
assessment of whether an innovative procedure truly beneﬁts the
patient. It is widely accepted that the future progress of surgery is
dependent on innovative solutions to contemporary problems. Yet the
future of surgical innovation is fraught with ethical concerns. Thus,
innovation is not only the key to surgical progress but also the greatest
challenge to the professionalism of surgeons.
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